Loading clinical trials...

A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy | Clinical Trials | Clareo Health

RECRUITINGPhase 2NCT06848231

A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

This is a Phase 2, double-blind, placebo-controlled, multi-center, Phase II, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and efficacy of Ya-101 in subjects with multip...

Lead sponsor: Yoda Therapeutics Inc.•6 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Email contact via Yoda Therapeutics Inc.

CONTACT

857-468-9328 [email protected]

Related studies

RECRUITINGPhase 2

An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

NCT07197866 · Multiple System Atrophy

RECRUITING

Pain and Autonomic Symptoms in Parkinson's Disease and Atypical Parkinsonisms

NCT05748028 · Parkinson Disease, Multiple System Atrophy

RECRUITINGPhase 1

[18F]F-DOPA Imaging in Patients With Autonomic Failure

NCT04246437 · Autonomic Failure, Pure Autonomic Failure, and more

RECRUITING

Synaptic Loss in Multiple System Atrophy

NCT05121012 · Multiple System Atrophy, Progressive Supranuclear Palsy (PSP)

RECRUITINGNA

Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension

NCT03042988 · Hypertension, Pure Autonomic Failure, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 10, 2025Terms

Trial snapshot

StatusRECRUITING

PhasePHASE2

Enrollment75

Start dateMar 2025

Last updatedSep 10, 2025

Condition

Multiple System Atrophy

Locations shown

UCLA Health

Los Angeles, California

Brigham and Women's Hospital

Boston, Massachusetts

Mayo Clinic

Rochester, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 10, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions